Clinical Trial Update: Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether adding azathioprine to Cimzia improves outcomes in active Crohn's disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Azathioprine (azathioprine)
• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: Gastroenterology Research of America | Conditions: Crohn's Disease | Phase 3 | Status: UNKNOWN